Provided by Tiger Trade Technology Pte. Ltd.

CARSGEN-B

16.000
+0.0100.06%
Volume:4.53M
Turnover:74.31M
Market Cap:9.12B
PE:-79.81
High:16.880
Open:16.180
Low:15.890
Close:15.990
52wk High:25.600
52wk Low:9.900
Shares:570.00M
HK Float Shares:570.00M
Volume Ratio:0.99
T/O Rate:0.79%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.200
ROE:-11.21%
ROA:-9.61%
PB:10.29
PE(LYR):-79.81
PS:64.17

Loading ...

BRIEF-Carsgen Therapeutics Says Yijie Concert Group Purchased 335,000 Shares From November 6 To December 17

Reuters
·
Dec 18, 2025

CARsgen Therapeutics - Yijie Concert Group Purchased 335,000 Shares From November 6 to December 17

THOMSON REUTERS
·
Dec 18, 2025

Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 30,000 Shares at HK$14.98 per Share

Stock News
·
Dec 18, 2025

HK Stock Buyback Summary | December 18

Stock News
·
Dec 18, 2025

CARSGEN-B Spent HK$6.737 Million to Repurchase 466,000 Shares on December 17

Deep News
·
Dec 18, 2025

HKEX Share Buyback Summary | December 17

Stock News
·
Dec 17, 2025

CARsgen Therapeutics Holdings Insider Ups Holding During Year

Simply Wall St.
·
Dec 17, 2025

CARSGEN-B (02171) Repurchases 1.01 Million Shares for HK$14.762 Million on December 16

Stock News
·
Dec 16, 2025

CARSGEN-B (02171) Repurchases 522,000 Shares for HK$7.9076 Million on December 15

Stock News
·
Dec 15, 2025

CARsgen Therapeutics Repurchases 522,000 Shares for HKD 7.91 Million, Files Disclosure with HKEX

Reuters
·
Dec 15, 2025

CARSGEN-B (02171) Repurchases 250,000 Shares for HK$3.8945 Million on December 12

Stock News
·
Dec 12, 2025

CARsgen Therapeutics Repurchases 250,000 Shares for HKD 3.89 Million, Files Disclosure with HKEX

Reuters
·
Dec 12, 2025

Hong Kong Stock Buyback Summary | December 12

Stock News
·
Dec 12, 2025

CARSGEN-B (02171) Repurchased 1.02 Million Shares for Approximately HK$15.89 Million on December 11, 2025

Stock News
·
Dec 11, 2025

Non-Executive Director Guo Huaqing Reduces Holdings in CARSGEN-B (02171) by 10,000 Shares at HK$17.7 Each

Stock News
·
Dec 11, 2025

CARsgen Announces Data of Allogeneic Bcma CAR-T Cell Therapy Ct0596 for Relapsed/Refractory Multiple Myeloma at the 2025 Ash Annual Meeting

THOMSON REUTERS
·
Dec 08, 2025

CARSGEN-B (02171): Preliminary Results of CT0596 Presented at 67th ASH Annual Meeting

Stock News
·
Dec 08, 2025

CARsgen Therapeutics Presents Preliminary Results for Allogeneic CAR T-Cell Therapy CT0596 at ASH 2025

Reuters
·
Dec 08, 2025

CARsgen's Zevor-Cel Approved in China for Relapsed/Refractory Multiple Myeloma

Reuters
·
Dec 07, 2025

10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled

Stock News
·
Dec 03, 2025